Belpointe Asset Management’s Biohaven BHVN Stock Holding History

Belpointe Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49	Closed	-$669	–	879
2023 Q1	$669	Buy	+49	New	+$780	﹤0.01%	3555

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Belpointe Asset Management's BHVN Position: Q2 2023 in Review

Belpointe Asset Management sold out of Biohaven (BHVN) in Q2 2023, closing a stake of 49 shares — an estimated $669 sold.

Belpointe Asset Management first reported a position in BHVN in Q1 2023 and held it in 1 quarter. The position peaked at $669 in Q1 2023. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2023.

Belpointe Asset Management reported no remaining Biohaven position as of Q2 2023 after selling out during the quarter.
Belpointe Asset Management sold 49 Biohaven shares in Q2 2023, an estimated $669.
Belpointe Asset Management first reported a position in Biohaven in Q1 2023 and held it in 1 quarter.
Belpointe Asset Management's Biohaven position peaked at $669 in Q1 2023.
188 funds tracked by Wall St. Rank held Biohaven as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.